EZH2 and neoplasm: Moreover, systemic nanoparticle delivery of siRNAs or antagomirs targeting tumor-assisting non-coding RNAs (such as EZH2, HOTAIR, and miR-298) into ovarian TECs may provide an additional option for combinatorial blocking of EOC tumor growth and angiogenesis [197,198,199].